Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
9.53
0.00 (0.00%)
At close: Jun 26, 2026, 4:00 PM EDT
9.52
-0.01 (-0.10%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Immatics Market Cap
Immatics has a market cap or net worth of $1.3 billion as of June 26, 2026. Its market cap has increased by 79.60% in one year.
Market Cap
1.30B
Enterprise Value
795.55M
1-Year Change
79.60%
Ranking
Category
Stock Price
$9.53
Market Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $1.30B, an increase of 654.28%. That is a compound annual growth rate of 30.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 1.30B | -7.57% |
| Dec 31, 2025 | 1.41B | 65.88% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MoonLake Immunotherapeutics | 1.47B |
| Ascentage Pharma Group International | 1.46B |
| MapLight Therapeutics | 1.45B |
| Novavax | 1.41B |
| Inhibrx Biosciences | 1.40B |
| Damora Therapeutics | 1.39B |
| Hemab Therapeutics Holdings | 1.29B |
| Jade Biosciences | 1.29B |